Filing Details

Accession Number:
0001610717-24-000432
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-22 17:58:38
Reporting Period:
2024-08-20
Accepted Time:
2024-08-22 17:58:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX Pharmaceutical Preparations (2834) 273521219
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654058 A. Sean Mccarthy C/O Cytomx Therapeutics, Inc.
151 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-20 37,500 $0.00 671,749 No 4 M Direct
Common Stock Disposition 2024-08-20 13,898 $1.23 657,851 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units (PSUs) Disposition 2024-08-20 37,500 $0.00 37,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 93,158 Indirect See footnote
Footnotes
  1. Represents vesting of a Performance Stock Unit ("PSU") award initially granted on August 10, 2022.
  2. Includes 197,500 restricted stock units.
  3. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs reported herein.
  4. Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
  5. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vested on December 17, 2023 upon achievement of a certain performance-based milestone. In connection with the vesting reported herein, the remaining 50% of the PSUs vested upon achievement of a certain performance-based milestone.